Aigen Investment Management LP Has $659,000 Stock Position in Globe Life Inc. (NYSE:GL)

Aigen Investment Management LP decreased its stake in Globe Life Inc. (NYSE:GL) by 16.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,906 shares of the company’s stock after selling 1,174 shares during the period. Aigen Investment Management LP’s holdings in Globe Life were worth $659,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. M&T Bank Corp boosted its stake in Globe Life by 12.2% during the fourth quarter. M&T Bank Corp now owns 20,769 shares of the company’s stock worth $2,316,000 after buying an additional 2,257 shares in the last quarter. Steward Partners Investment Advisory LLC boosted its stake in Globe Life by 61.5% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 24,665 shares of the company’s stock worth $2,751,000 after buying an additional 9,395 shares in the last quarter. Plato Investment Management Ltd acquired a new stake in Globe Life during the fourth quarter worth $84,000. Jones Financial Companies Lllp boosted its stake in Globe Life by 685.1% during the fourth quarter. Jones Financial Companies Lllp now owns 1,209 shares of the company’s stock worth $135,000 after buying an additional 1,055 shares in the last quarter. Finally, SRS Capital Advisors Inc. boosted its stake in Globe Life by 18.8% during the fourth quarter. SRS Capital Advisors Inc. now owns 784 shares of the company’s stock worth $87,000 after buying an additional 124 shares in the last quarter. Institutional investors and hedge funds own 81.61% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on GL shares. Evercore ISI upgraded shares of Globe Life from an “in-line” rating to an “outperform” rating and lifted their price target for the stock from $132.00 to $143.00 in a research note on Wednesday, January 8th. Keefe, Bruyette & Woods lifted their price target on shares of Globe Life from $137.00 to $145.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 12th. Morgan Stanley lifted their price target on shares of Globe Life from $125.00 to $126.00 and gave the stock an “equal weight” rating in a research note on Friday, February 28th. Jefferies Financial Group lifted their price objective on Globe Life from $107.00 to $114.00 and gave the company a “hold” rating in a report on Tuesday, December 10th. Finally, Wells Fargo & Company lifted their price objective on Globe Life from $126.00 to $141.00 and gave the company an “overweight” rating in a report on Wednesday, February 19th. Five investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $135.60.

Insider Activity at Globe Life

In other Globe Life news, CEO Frank M. Svoboda sold 11,000 shares of the business’s stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $122.31, for a total transaction of $1,345,410.00. Following the completion of the sale, the chief executive officer now directly owns 18,948 shares of the company’s stock, valued at approximately $2,317,529.88. The trade was a 36.73 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Mark A. Blinn sold 3,000 shares of the business’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $113.23, for a total value of $339,690.00. Following the sale, the director now directly owns 5,122 shares of the company’s stock, valued at $579,964.06. This represents a 36.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 61,338 shares of company stock valued at $7,239,630 over the last ninety days. 1.51% of the stock is owned by insiders.

Globe Life Stock Performance

Globe Life stock opened at $124.56 on Friday. The stock has a 50-day simple moving average of $119.25 and a 200 day simple moving average of $110.99. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50. Globe Life Inc. has a 12-month low of $38.95 and a 12-month high of $131.39. The stock has a market capitalization of $10.44 billion, a price-to-earnings ratio of 10.42 and a beta of 0.77.

Globe Life (NYSE:GL) last released its quarterly earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. On average, research analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.

Globe Life Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Thursday, April 3rd will be issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.87%. This is a boost from Globe Life’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Thursday, April 3rd. Globe Life’s payout ratio is currently 9.04%.

Globe Life Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.